The annexin A2 pseudogenes (ANXA2P1, ANXA2P2, and ANXA2P3) are significantly upregulated in glioma and are associated with adverse outcome of glioma patients (13). The gene discussed is ANXA2P2; the disease is central nervous system cancer.